TABLE 3.
ID | Relative Bioavailability |
|
---|---|---|
FAUC | FXu | |
1 | 0.75 | 0.70 |
2 | 1.20 | 0.66 |
3 | 0.92 | 0.98 |
4 | 0.98 | 0.65 |
5 | 0.50 | 0.66 |
6 | 0.73 | 0.91 |
7 | 7.32 | 3.05 |
8 | 0.91 | 0.77 |
9 | 1.29 | 1.41 |
10 | 1.14 | 1.03 |
11 | 1.21 | 1.90 |
12 | 0.88 | 1.09 |
13 | 0.76 | 0.83 |
14 | 1.53 | 1.33 |
15 | 1.80 | 1.36 |
16 | 1.06 | 1.02 |
17 | 1.56 | 1.67 |
18 | 1.22 | 2.19 |
19 | N.A. | 5.01 |
20 | 1.02 | 1.20 |
21 | 2.11 | 1.87 |
22 | 0.53 | 0.54 |
23 | 1.43 | 1.13 |
24 | 0.82 | 1.10 |
25 | 0.83 | 0.57 |
Mean | 1.35 | 1.35 |
SD | 1.33 | 0.96 |
90% CI | 0.93 −1.35 | 0.95 −1.38 |
N.A., not available because the plasma concentration of [D10]PheT after smoking was below the limit of quantitation.